418
Participants
Start Date
June 30, 2011
Primary Completion Date
September 30, 2012
Study Completion Date
June 30, 2015
BMS-945429 Placebo
Injection, Subcutaneous, 0 mg, Every 4 weeks, Day 1 - Week 24 only
BMS-945429
Injection, Subcutaneous, 25 mg, Every 4 weeks, Day 1 - Week 24 only
BMS-945429
Injection, Subcutaneous, 100 mg, Every 4 weeks, 48 weeks
BMS-945429
Injection, Subcutaneous, 200 mg, Every 4 weeks, Week 25 - Week 48
BMS-945429
Injection, Subcutaneous, 200 mg, Every 4 weeks, 48 weeks
Methotrexate
Tablets, Oral, 15 mg, Weekly, Day 1 - Week 24 only
Methotrexate
Tablets, Oral, 15 mg, Weekly, 48 weeks
Methotrexate Placebo
Tablets, Oral, 0 mg, Weekly, Day 1 - Week 24 only
Methotrexate
Tablets, Oral, 15 mg, Weekly, Week 25 - Week 48 only
Adalimumab Placebo
Injection, Subcutaneous, 0 mg, Every 2 weeks, 48 weeks
Adalimumab
Injection, Subcutaneous, 40 mg, Every 2 weeks, 48 weeks
Local Institution, Taoyuan District
Local Institution, Taichung
Local Institution, Changhua
Local Institution, Kaohsiung City
Local Institution, Capital Federal
Local Institution, Budapest
Local Institution, Brussels
Local Institution, Capital Federal
Local Institution, Capital Federal
Local Institution, Capital Federal
Local Institution, Rosario
Local Institution, Hasselt
Local Institution, San Miguel de Tucumán
Local Institution, Durban
Local Institution, Debrecen
Local Institution, Córdoba
Local Institution, San Juan
Local Institution, Gyula
Local Institution, Pinelands, Cape Town
Local Institution, Panorama
Local Institution, Tygerberg
Local Institution, Veszprém
Local Institution, Mexico City
Local Institution, Berlin
Local Institution, A Coruña
Local Institution, Santiago de Compostela
Altoona Center For Clinical Research, Duncansville
East Penn Rheumatology Associates, P.C., Bethlehem
Local Institution, Madrid
Box Arthritis And Rheumatology Of The Carolinas, Pllc, Charlotte
Local Institution, Bordeaux
Local Institution, Padua
Local Institution, Juiz de Fora
Local Institution, Chambray-lès-Tours
Local Institution, Santander
Arthritis Associates Of Mississippi, Jackson
Local Institution, Seville
Local Institution, Reggio Emilia
Local Institution, Guadalajara
Local Institution, Guadalajara
Local Institution, Cologne
Local Institution, Morelia
Local Institution, Poznan
Rockford Orthopedic Associates, Llc., Rockford
Quincy Medical Group, Quincy
Local Institution, Monterrey
Local Institution, Strasbourg
Physician Research Collaboration, Llc, Lincoln
Health Research Of Oklahoma, Oklahoma City
Local Institution, Goiânia
Local Institution, San Luis Potosí City
Local Institution, Curitiba
Local Institution, Napoli
Local Institution, Culiacán
Local Institution, Curitiba
Sun Valley Arthritis Center, Ltd., Peoria
Local Institution, Porto Alegre
San Diego Arthritis Medical Clinic, San Diego
Local Institution, Würzburg
Seattle Rheumatology Associates, Seattle
Local Institution, Moscow
Local Institution, Yaroslavl
Local Institution, Saint Petersburg
Local Institution, Kazan'
Local Institution, Yekaterinburg
Local Institution, Novosibirsk
Local Institution, Bunkyo-ku
Local Institution, Shinjuku-Ku
Local Institution, Toshima-ku
Local Institution, Chiba
Local Institution, Nagano
Local Institution, Shizuoka
Local Institution, Osaka
Local Institution, Kato-shi
Local Institution, Higashi-hiroshima-shi
Local Institution, Kitakyushu-shi
Local Institution, Nagasaki
Local Institution, Sasebo-shi
Local Institution, Miyazaki
Local Institution, Tomigusuku-shi
New England Research Associates, Llc, Trumbull
Clinical Pharmacology Study Group, Worcester
Local Institution, São Paulo
Local Institution, São Paulo
Local Institution, Montreal
Local Institution, Québec
Centre De Recherche Musculo-Squelettique, Trois-Rivières
Local Institution, Prague
Local Institution, Prague
Local Institution, Leipzig
Local Institution, Amsterdam
Local Institution, Katowice
Local Institution, Krakow
Local Institution, Warsaw
Local Institution, Warsaw
Local Institution, Pretoria
Local Institution, Pretoria
Local Institution, Daegu
Local Institution, Seoul
Local Institution, Seoul
Lead Sponsor
CSL Behring
INDUSTRY